Understanding Options In Direct-To-Patient Clinical Supply

Direct-to-Patient clinical supply is an essential component for traditional and decentralized trials. Broadly referred to as DTP, Direct-to-Patient supply enables clinical trial participants to receive their treatments in the convenience and comfort of their own home and reduces, or even eliminates, the need to travel to a clinical site.

FlexDirect^® Direct-to-Patient (DTP) services from Catalent enable clinical supplies to be sent directly to patients’ homes, reducing or even eliminating the need for in person clinical site visits. Services can be flexible depending upon the study protocol, the patient recruitment strategy being employed and the geographic scope of the study.